arrow
Back
C

Christian Poehlein

Rambam Health Care Campus

31H-index
151Paper Count
7.0KCitation Count
Published Papers 31
Publication Date
Steroidogenesis inhibitor opevesostat (MK-5684) for metastatic castration-resistant prostate cancer: OMAHA-003 and OMAHA-004 trial designs
err2026-02-01
err0
errOAAI
errYu, Evan Y.; Gratzke, Christian; Burotto, Mauricio; Zhang, Alison Y.; Levesque, Eric; Ortega, Francisco; Peer, Avivit; Vile, Donald; Chen, Zheng Hong; Song, Yue; Schloss, Charles; Todoric, Jelena; Garratt, Chris; Poehlein, Christian; Antonarakis, Emmanuel S.; Fizazi, Karim
errShare
errSave
Prostate-specific Antigen and Objective Response Analyses in PROpel: Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone as First-line Therapy for Metastatic Castration-resistant Prostate Cancer
err2025-11-04
err0
errOAAI
errFred Saad; Andrew J. Armstrong; Mototsugu Oya; Neal Shore; Giuseppe Procopio; João Daniel Guedes; Cagatay Arslan; Niven Mehra; Emma Brown; Jae Young Joung; Mikio Sugimoto; Oliver Sartor; Christian Poehlein; Elizabeth A. Harrington; Jinyu Kang; Noel Clarke
errShare
errSave
Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: the randomized, double-blind, phase III KEYNOTE-991 study☆
err2025-05-16
err0
PREAI
errC. Gratzke; M. Özgüroğlu; A. Peer; M.A.N. Sendur; M. Retz; J.C. Goh; W. Loidl; G. Jayram; S.-S. Byun; C. Kwak; M. Kwiatkowski; R. Manneh Kopp; J.C.V. Limón; J.F.E. Penagos; U. De Giorgi; K.M. da Trindade; C. Niu; Y. Liu; C.H. Poehlein; J.M. Piulats
errShare
errSave
Efficacy and Safety of Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone in the First-line Treatment of Patients with Asymptomatic/Mildly Symptomatic and Symptomatic Metastatic Castration-resistant Prostate Cancer: Analyses from the Phase 3 PROpel Trial
err2024-10-01
err0
errOAAI
errNoel W. Clarke; Andrew J. Armstrong; Mototsugu Oya; Neal Shore; Giuseppe Procopio; João Daniel Guedes; Cagatay Arslan; Niven Mehra; Francis Parnis; Emma Brown; Friederike Schlürmann; Jae Young Joung; Mikio Sugimoto; Oliver Sartor; Christian Poehlein; David McGuinness; Arnold Degboe; Fred Saad
errShare
errSave
Pembrolizumab plus enzalutamide for metastatic castration-resistant prostate cancer progressing on enzalutamide: cohorts 4 and 5 of the phase 2 KEYNOTE-199 study
err2024-08-12
err1
PREAI
errGraff, Julie N.; Hoimes, Christopher J.; Gerritsen, Winald R.; Vaishampayan, Ulka N.; Elliott, Tony; Hwang, Clara; ten Tije, Albert J.; Omlin, Aurelius; McDermott, Raymond S.; Fradet, Yves; Tagawa, Scott T.; Kilari, Deepak; Ferrario, Cristiano; Uemura, Hiroji; Jones, Robert J.; Fukasawa, Satoshi; Peer, Avivit; Niu, Cuizhen; Poehlein, Christian H.; Qiu, Ping; Suttner, Leah; de Wit, Ronald; Schloss, Charles; de Bono, Johann S.; Antonarakis, Emmanuel S.
errShare
errSave
Pembrolizumab and Enzalutamide in Patients with Abiraterone Acetate-Pretreated Metastatic Castration-Resistant Prostate Cancer: Cohort C of the Phase 1b/2 KEYNOTE-365 Study
err2024-06-01
err0
errOAAI
errYu, Evan Y.; Berry, William R.; Gurney, Howard; Retz, Margitta; Conter, Henry J.; Laguerre, Brigitte; Fong, Peter C. C.; Ferrario, Cristiano; Todenhofer, Tilman; Gravis, Gwenaelle; Piulats, Josep M.; Emmenegger, Urban; Shore, Neal D.; Romano, Emanuela; Mourey, Loic; Li, Xin Tong; Poehlein, Christian H.; Schloss, Charles; Appleman, Leonard J.; Bono, Johann S. de
errShare
errSave
Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D
err2024-06-01
err0
errOAAI
errEvan Y. Yu; Cristiano Ferrario; Mark D. Linch; Michael Stoeckle; Brigitte Laguerre; Jose A. Arranz; Tilman Todenhöfer; Peter C. Fong; Josep M. Piulats; William Berry; Urban Emmenegger; Loic Mourey; Anthony M. Joshua; Nataliya Mar; Leonard J. Appleman; Henry J. Conter; Gwenaelle Gravis; Xin Tong Li; Charles Schloss; Christian Poehlein; Johann S. de Bono
errShare
errSave
Pembrolizumab (pembro) plus enzalutamide (enza) and androgen deprivation therapy (ADT) for patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC): Randomized double-blind phase III KEYNOTE-991 study
err2023-10-01
err5
errOAAI
errGratzke, C. J.; Ozguroglu, M.; Peer, A.; Sendur, M. A. N.; Retz, M.; Goh, J. C. H.; Loidl, W. C.; Jayram, G.; Byun, S-S.; Kwak, C.; Kwiatkowski, M.; Kopp, R. Manneh; Limon, J. C. Vazquez; Penagos, J. F. Escobar; De Giorgi, U. F. F.; Trindade, K. M. D.; Niu, C.; Liu, Y.; Poehlein, C. H.; Rodriguez, J. M. Piulats
errShare
errSave
Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study (vol 83, pg 15, 2023)
err2023-03-01
err3
errOAAI
errYu, Evan Y.; Piulats, Josep M.; Gravis, Gwenaelle; Fong, Peter C. C.; Todenhoefer, Tilman; Laguerre, Brigitte; Arranz, Jose A.; Oudard, Stephane; Massard, Christophe; Heinzelbecker, Julia; Nordquist, Luke T.; Carles, Joan; Kolinsky, Michael P.; Augustin, Marinela; Gurney, Howard; Tafreshi, Ali; Li, Xin Tong; Qiu, Ping; Poehlein, Christian H.; Schloss, Charles; de Bono, Johann S.
errShare
errSave
KEYNOTE-991: pembrolizumab plus enzalutamide and androgen deprivation for metastatic hormone-sensitive prostate cancer
err2023-01-27
err12
errOAAI
errGratzke, Christian; Kwiatkowski, Mariusz; Giorgi, Ugo De; Martins da Trindade, Karine; De Santis, Maria; Armstrong, Andrew J.; Niu, Cuizhen; Liu, Yingjie; Poehlein, Christian Heinrich
errShare
errSave
Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study
err2023-01-01
err35
errOAAI
errYu, Evan Y.; Piulats, Josep M.; Gravis, Gwenaelle; Fong, Peter C. C.; Todenhofer, Tilman; Laguerre, Brigitte; Arranz, Jose A.; Oudard, Stephane; Massard, Christophe; Heinzelbecker, Julia; Nordquist, Luke T.; Carles, Joan; Kolinsky, Michael P.; Augustin, Marinela; Gurney, Howard; Tafreshi, Ali; Li, Xin Tong; Qiu, Ping; Poehlein, Christian H.; Schloss, Charles; de Bono, Johann S.
errShare
errSave
Testing for homologous recombination repair or homologous recombination deficiency for poly (ADP-ribose) polymerase inhibitors: A current perspective
err2023-01-01
err23
errOAAI
errHerzog, Thomas J.; Vergote, Ignace; Gomella, Leonard G.; Milenkova, Tsveta; French, Tim; Tonikian, Raffi; Poehlein, Christian; Hussain, Maha
errShare
errSave
Olaparib tolerability and common adverse-event management in patients with metastatic castration-resistant prostate cancer: Further analyses from the PROfound study
err2022-07-01
err9
errOAAI
errRoubaud, Guilhem; Oezgueroglu, Mustafa; Penel, Nicolas; Matsubara, Nobuaki; Mehra, Niven; Kolinsky, Michael P.; Procopio, Giuseppe; Feyerabend, Susan; Joung, Jae Young; Gravis, Gwenaelle; Nishimura, Kazuo; Gedye, Craig; Padua, Charles; Shore, Neal; Thiery-Vuillemin, Antoine; Saad, Fred; van Alphen, Robbert; Carducci, Michael A.; Desai, Chintu; Brickel, Neil; Poehlein, Christian; Del Rosario, Paula; Fizazi, Karim
errShare
errSave
Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study
err2022-07-01
err44
errOAAI
errYu, Evan Y.; Kolinsky, Michael P.; Berry, William R.; Retz, Margitta; Mourey, Loic; Piulats, Josep M.; Appleman, Leonard J.; Romano, Emanuela; Gravis, Gwenaelle; Gurney, Howard; Bogemann, Martin; Emmenegger, Urban; Joshua, Anthony M.; Linch, Mark; Sridhar, Srikala; Conter, Henry J.; Laguerre, Brigitte; Massard, Christophe; Li, Xin Tong; Schloss, Charles; Poehlein, Christian H.; de Bono, Johann S.
errShare
errSave
PHASE 1B/2 KEYNOTE-365 COHORT I: PLATINUM-CONTAINING CHEMOTHERAPY ALONE OR IN COMBINATION WITH PEMBROLIZUMAB FOR TREATMENT-EMERGENT NEUROENDOCRINE PROSTATE CARCINOMA
err2021-11-10
err0
errOAAI
errDe Bono, Johann; Shore, Neal; Kramer, Gero; Joshua, Anthony; Li, Xin Tong; Poehlein, Christian; Schloss, Charles; Yu, Evan
errShare
errSave
Association between homologous recombination repair mutations and response to pembrolizumab (pembro) plus olaparib (ola) in metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 Cohort A biomarker analysis
err2021-09-01
err7
errOAAI
errYu, E.; Piulats, J. M.; Gravis, G.; Fong, P.; Todenhoefer, T.; Laguerre, B.; Arranz, J.; Oudard, S.; Massard, C.; Stoeckle, M.; Nordquist, L. T.; Carles, J.; Huang, M.; Li, Y.; Qiu, P.; Poehlein, C. H.; Schloss, C.; de Bono, J.
errShare
errSave
Biomarker analysis of men with enzalutamide (enza)resistant metastatic castration-resistant prostate cancer (mCRPC) treated with pembrolizumab (pembro) plus enza in KEYNOTE-199
err2021-09-01
err0
errOAAI
errGraff, J. N.; Tagawa, S.; Hoimes, C.; Gerritsen, W.; Vaishampayan, U. N.; Elliott, T.; Hwang, C.; Ten Tije, A. J.; Omlin, A. G.; McDermott, R. S.; De Wit, R.; Qiu, P.; Poehlein, C.; Kim, J.; Suttner, L.; Cristescu, R.; Marton, M. J.; Schloss, C.; de Bono, J. S.; Antonarakis, E. S.
errShare
errSave
Pembrolizumab (pembro) plus olaparib in patients with docetaxel-pretreated metastatic castration-resistant prostate cancer (mCRPC): Update of KEYNOTE-365 cohort A with a minimum of 11 months of follow-up for all patients
err2021-09-01
err7
errOAAI
errYu, E.; Piulats, J. M.; Gravis, G.; Fong, P. C. C.; Todenhoefer, T.; Laguerre, B.; Arranz Arija, J. A.; Oudard, S.; Massard, C.; Stoeckle, M.; Nordquist, L. T.; Carles, J.; Kolinsky, M. P.; Augustin, M.; Gurney, H.; Tafreshi, A.; Li, X. T.; Poehlein, C. H.; Schloss, C.; de Bono, J. S.
errShare
errSave